Drug Shortage Report for DOXORUBICIN

Last updated on 2019-05-02 History
Report ID 40515
Drug Identification Number 02410397
Brand name DOXORUBICIN
Common or Proper name Doxorubicin
Company Name PFIZER CANADA ULC
Market Status MARKETED
Active Ingredient(s) DOXORUBICIN HYDROCHLORIDE
Strength(s) 2MG
Dosage form(s) SOLUTION
Route of administration INTRAVENOUS INTRAVESICAL
Packaging size 1 x 25mL
ATC code L01DB
ATC description CYTOTOXIC ANTIBIOTICS AND RELATED SUBSTANCES
Reason for shortage Disruption of the manufacture of the drug.
Anticipated start date
Actual start date 2018-03-13
Estimated end date Unknown
Actual end date 2019-05-01
Shortage status Resolved
Updated date 2019-05-02
Company comments
Health Canada comments
Contact Address 17300 TRANS-CANADA HIGHWAY
KIRKLAND, QUEBEC
CANADA H9J 2M5
Company contact information Customer Service / service à la clientèle : 1-888-999-8750 Email / courriel: PharmaCustomerServiceDept@pfizer.com

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v23 2019-05-02 French Compare
v22 2019-05-02 English Compare
v21 2019-02-26 French Compare
v20 2019-02-26 English Compare
v19 2019-01-16 French Compare
v18 2019-01-16 English Compare
v17 2018-12-17 French Compare
v16 2018-12-17 English Compare
v15 2018-10-23 French Compare
v14 2018-10-23 English Compare
v13 2018-09-26 French Compare
v12 2018-09-26 English Compare
v11 2018-06-08 French Compare
v10 2018-06-08 English Compare
v9 2018-05-29 French Compare
v8 2018-05-29 English Compare
v7 2018-04-02 French Compare
v6 2018-04-02 English Compare
v5 2018-03-22 French Compare
v4 2018-03-22 English Compare

Showing 1 to 20 of 23